PACLITAXEL PACLITAXEL
Active substance: paclitaxel
INJECTION, SOLUTION · PACLITAXEL 6 mg/mL
United StatesActive
Marketing holder: Gland Pharma Limited
Verified 2026-10-09 · openFDA NDC
Analogues in other countries- Source: openFDA NDC
- Countries with the substance registered: 3
- PACLITAXEL · 6 mg/mL
Products with the same active substance registered in other countries.
| Country | Products |
|---|---|
| RU 50 |
|
| EU 6 |
|
Control by country
- Russiaprescription only
Source: GRLS (Russian state register) · record 01a120c3-2fc8-78e1-9c06-652f7c137dc8,01a120c3-2ff5-7f03-b200-0465a1ed8dd6,01a120c3-4619-733b-8e91-46356904f3c6,01a120c3-4a91-77bd-94d5-c9265199d89e,01a120c3-4c3c-77b0-95ce-6d15124db77d;count=40 · valid from 2026-10-09 · verified 2026-10-09
- United Statesprescription only
Source: openFDA NDC · record 01a1208c-4d0c-7711-830e-9af35bb4c59a,01a1208c-c6b6-7eef-ba77-2db81259a362,01a1208c-e072-7146-9dc9-d7a854e8b66d,01a1208c-e079-7675-886b-15bc53a21287,01a1208d-6046-709c-85c9-02b26af08532;count=41 · valid from 2026-10-09 · verified 2026-10-09
- Registration number
- 68083-178
- Registration status
- Active
- Dispensing
- Prescription only
- Route
- INTRAVENOUS
- product · openFDA NDC · 68083-178 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 68083-178 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 68083-178 · Verified 2026-10-09 · open in source